PatchSiren

PatchSiren cyber security CVE debrief

CVE-2023-6515 Mia Technology Inc. CVE debrief

CVE-2023-6515 is a high-severity authorization bypass in Mia Technology’s MIA-MED caused by a user-controlled key issue that can lead to authentication abuse. The vulnerability affects MIA-MED versions before 1.0.7 and is scored 8.8 (HIGH). The NVD record shows network-based exploitation with low attack complexity and low privileges required, while the USOM advisory maps the weakness to CWE-639.

Vendor
Mia Technology Inc.
Product
MİA-MED
CVSS
HIGH 8.8
CISA KEV
Not listed in stored evidence
Original CVE published
2024-02-08
Original CVE updated
2026-05-20
Advisory published
2024-02-08
Advisory updated
2026-05-20

Who should care

Security teams, application owners, and administrators running MIA-MED before 1.0.7 should prioritize this issue, especially if the application is exposed to untrusted users or integrated into sensitive clinical or operational workflows.

Technical summary

The vulnerability is described as an authorization bypass through a user-controlled key. Based on the NVD CVSS vector (CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H), exploitation is network-reachable, requires low privileges, and can have high impact on confidentiality, integrity, and availability. USOM associates the issue with CWE-639, indicating an access-control weakness tied to improper authorization checks.

Defensive priority

High. This is a remotely reachable authorization flaw with high impact and a public advisory trail. Remediation should be treated as urgent for any affected MIA-MED deployment.

Recommended defensive actions

  • Upgrade MIA-MED to version 1.0.7 or later.
  • Review access-control and authorization logic around any user-controlled keys or identifiers.
  • Audit logs for unexpected privilege use, account switching, or abnormal authorization failures.
  • Restrict exposure of MIA-MED to trusted networks and authenticated administrative paths until patched.
  • Validate that compensating controls do not rely on client-supplied values for authorization decisions.

Evidence notes

The vulnerability description and affected-version boundary come from the NVD CVE record and associated reference data. NVD lists the affected CPE range as MIA-MED versions before 1.0.7. USOM’s advisory is referenced in the NVD record and includes CWE-639. The record was published on 2024-02-08 and later modified on 2026-05-20; those dates reflect record timing, not remediation timing.

Sources and references

Verified primary and authoritative sources

  • CVE-2023-6515 CVE Program record

    Publisher, destination, and source semantics verified

    URL: https://www.cve.org/CVERecord?id=CVE-2023-6515

    CVE Program - Official CVE Program record with source-provided CVE metadata.

  • CVE-2023-6515 NVD vulnerability detail

    Publisher, destination, and source semantics verified

    URL: https://nvd.nist.gov/vuln/detail/CVE-2023-6515

    NIST National Vulnerability Database - Official NIST NVD detail page and source-specific vulnerability assessment.

Supplemental references

Methodology and review provenance

AI-assisted synthesis based on stored public vulnerability evidence. System validation, approval state, and publication status do not by themselves establish human review of this revision. PatchSiren helps prioritize defensive review and does not prove exposure or remediation on any system.